GlaxoSmithKline

GSK To Boost Spending Power Of Pharma Business Post Break-up

GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analyst...

GSK's Consumer Healthcare Business Posts Third-Quarter Growth

The consumer healthcare division of GlaxoSmithKline, which includes brands including Panadol and Aquafresh, has posted £2.5 billion (€2.9 billio...

GSK, Pfizer Looking To Realise Cost Savings Of £500m Per Annum From Tie-Up

GlaxoSmithKline has announced the completion of its tie-up with Pfizer's consumer health portfolio, adding that the joint venture is expected to realise an...

Turnover In GSK's Consumer Healthcare Division Up 5% In Q2

GlaxoSmithKline has posted a 5% growth in turnover in its consumer healthcare division, to £1.9 billion (€2.13 billion), in the second...

GSK Kicks Off Sale Of €1.1bn Consumer Health Brands: Reports

GlaxoSmithKline (GSK) has kicked off the sale of a number of consumer health brands as it seeks to raise about £1 billion (€1.13 billion) before...

GlaxoSmithKline Chairman Hampton To Step Down

GlaxoSmithKline Plc Chairman Philip Hampton will step down after more than three and a half years in the role, Britain's biggest drugmaker announced on Mon...

GSK Beats Q3 Forecasts, Nudges Up Guidance

Strong demand for a new shingles vaccine Shingrix helped pharmaceutical firm GlaxoSmithKline to post a better-than-expected 14% rise in third-quarter earni...

GSK Seeks Mid-Sept Bids For $4 Billion Indian Horlicks Unit

GlaxoSmithKline is seeking initial bids by mid-September for its India-focussed Horlicks health nutrition business, which is expected to fetch more than $4...